CBER’s Long Goodbye: Biologics Approval Time Jumps To 30 Months In 2002
The average approval time for new biologic therapeutics and vaccines in 2002 was 30.1 months, an 11-month increase from 2001
The average approval time for new biologic therapeutics and vaccines in 2002 was 30.1 months, an 11-month increase from 2001